Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Sun Pharmaceutical Industries, Tata Power, Fortis Healthcare: Rahul Shah

      Rahul Shah, Associate VP at Motilal Oswal is of the view that one can buy Sun Pharmaceutical Industries, Tata Power and Fortis Healthcare.

    • Buy Sun Pharma, hold GMR Infra: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Sun Pharma and hold GMR Infra.

    • Sell Fortis Healthcare; buy Raymond, Ashok Leyland: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com advises selling Fortis Healthcare.

    • Buy Titan, Tata Elxsi, Ceat, Kajaria Ceramics, Bajaj Auto, Sun Pharma: VK Sharma

      VK Sharma, Head - PCG and Capital Market Strategy at HDFC Securities recommends buying Titan Company, Tata Elxsi, Ceat, Kajaria Ceramics, Bajaj Auto and Sun Pharmaceutical Industries.

    • 5 stocks where brokerages retained buy post Q2 results can give up to 30% upside

      The pharma companies have posted mix earnings in the quarter ended September 2017 on the back pricing pressure and increased competition.

    • Sell Sun Pharmaceutical Industries, buy Maruti Suzuki: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one can sell Sun Pharmaceutical Industries and buy Maruti Suzuki.

    • Buy, Sell, Hold: These 7 stocks on analysts' radar today

      Axis Capital has maintained its hold rating on Bank of Baroda with a target price of Rs 180 per share post earnings, as the research house does not see huge upside post recent run-up.

    • Here are fundamental trading ideas from SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh, Anuj Singhal, and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks and sectors.

    • Sun Pharmaceutical – is the dawn near?

      The management maintained its earlier guidance of single-digit revenue decline in FY2018 and EBITDA margin performance of 20-22% in the second half.

    • Sell Cummins India, L&T Finance; buy Ashok Leyland, Hexaware, Dalmia Bharat, Bata: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Cummins India and L&T Finance Holdings and can buy Ashok Leyland, Hexaware Technologies, Dalmia Bharat and Bata India.

    • Sell M&M Financial; buy Sun Pharma, Tata Steel, Voltas, Page Industries: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Mahindra & Mahindra Financial Services and buy Sun Pharmaceutical Industries, Tata Steel, Voltas and Page Industries.

    • Buy Cadila Healthcare, REC, Sun Pharma, SRF: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Cadila Healthcare, REC, Sun Pharma and SRF.

    • Sell Capital First, LIC Housing; buy Balkrishna Industries, Hindalco, UltraTech: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Capital First and LIC Housing Finance and can buy Balkrishna Industries, Hindalco Industries and UltraTech Cement.

    • Buy Petronet LNG, India Cements; hold Sun Pharma, RIL likely to test Rs 1,500: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Petronet LNG and India Cements while one can hold Sun Pharma while Reliance Industries is likely to test Rs 1,500.

    • Buy Ashok Leyland, Divis Laboratories, RIL, Torrent Power; sell LIC Housing: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ashok Leyland, Divis Laboratories, Reliance Industries and Torrent Power and can sell LIC Housing Finance.

    • Buy Sun Pharma, PTC India: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one may buy Sun Pharmaceutical Industries and PTC India.

    • Hold Biocon, target Rs 450: Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may hold Biocon.

    • Buy Cipla, Sun Pharm, M&M Financial Services, Tata Chemicals, Vedanta: VK Sharma

      VK Sharma, Head - PCG and Capital Market Strategy at HDFC Securities recommends buying Cipla, Sun Pharmaceutical Industries, Mahindra & Mahindra Financial Services, Tata Chemicals and Vedanta and advises a bull spread in Tata Communications.

    • Nifty likely to open lower with crucial support at 10150; buy Sun Pharma, Tata Motors: Prakash Gaba

      According to Technical Analyst Prakash Gaba of prakashgaba.com, the crucial support for the Nifty is at 10150 and the resistance is at 10315-10537. On the other hand, Bank Nifty has support at 25000 and resistance at 24534.

    • Buy Federal Bank, Bajaj Auto, Mahindra & Mahindra, Sun Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Federal Bank, Bajaj Auto, Mahindra & Mahindra and Sun Pharma.

    • Market Update: Nifty above 10K; Bharti Infratel hits 1-yr high, Hindalco, Auro Pharma top gainers

      Nifty added on to its morning gains on Thursday with the index inching up 47.45 points at 10,032.80 while the Sensex added 132.86 points at 31,966. Vedanta, Lupin, Sun Pharma along with TCS were some of the top gainers in the Nifty.

    • Sell Can Fin Home, Cummins India; buy Bharti Infratel, Havells India: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can sell Can Fin Home and Cummins India and can buy Bharti Infratel and Havells India.

    • Market Update: Nifty clings above 10K as midcaps shine; Bharti Infratel, Hindalco top gainers

      The midcap index was the outperforming sector in the early hours of trade led by Biocon, Bharat Financial Inclusion, JSW Energy and Hindustan Zinc while Bharti Infratel followed by Hindalco Industries and Sun Pharmaceutical Industries were the top gainers.

    • Neutral on Sun Pharma; women healthcare portfolio positive for Lupin: HDFC Securities

      Sun Pharmaceutical Industries gets a breather; a sign of relief after the US Food and Drug Administration (US FDA) closed the inspection and gave a clean chit to their Dadra unit.

    • Buy, Sell, Hold: 3 stocks being tracked by analysts today

      Sun Pharma and Lupin are on the radar of investors on Thursday.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347